Healthcare provider profile · identity verified

Keri Ann Benjamin, ARNP

Nurse Practitioner · HUMBOLDT, IA · NPI 1154685964

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	327	79
Omeprazole	Omeprazole	318	71
Levothyroxine Sodium	Levothyroxine Sodium	316	76
Losartan Potassium	Losartan Potassium	316	82
Lisinopril	Lisinopril	259	69
Metoprolol Succinate	Metoprolol Succinate	249	63
Atorvastatin Calcium	Atorvastatin Calcium	247	67
Rosuvastatin Calcium	Rosuvastatin Calcium	188	53
Ozempic	Semaglutide	180	27
Pantoprazole Sodium	Pantoprazole Sodium	134	32
Potassium Chloride	Potassium Chloride	124	35
Simvastatin	Simvastatin	118	29
Gabapentin	Gabapentin	116	29
Metformin Hcl Er	Metformin Hcl	111	26
Oxybutynin Chloride Er	Oxybutynin Chloride	108	19
Albuterol Sulfate Hfa	Albuterol Sulfate	95	42
Metformin Hcl	Metformin Hcl	94	20
Escitalopram Oxalate	Escitalopram Oxalate	89	24
Glipizide Er	Glipizide	89	21
Prednisone	Prednisone	87	53
Tramadol Hcl	Tramadol Hcl	86	25
Carvedilol	Carvedilol	84	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	27
Montelukast Sodium	Montelukast Sodium	84	21
Eliquis	Apixaban	81	13
Alprazolam	Alprazolam	76	12
Hydrochlorothiazide	Hydrochlorothiazide	74	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	21
Sertraline Hcl	Sertraline Hcl	71	17
Tresiba Flextouch U-200	Insulin Degludec	71	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	65	13
Warfarin Sodium	Warfarin Sodium	65	suppressed
Xarelto	Rivaroxaban	64	suppressed
Mounjaro	Tirzepatide	62	suppressed
Ezetimibe	Ezetimibe	61	17
Furosemide	Furosemide	61	21
Allopurinol	Allopurinol	60	12
Ropinirole Hcl	Ropinirole Hcl	60	11
Trazodone Hcl	Trazodone Hcl	60	18
Pregabalin	Pregabalin	58	12
Amitriptyline Hcl	Amitriptyline Hcl	56	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	56	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	suppressed
Famotidine	Famotidine	54	16
Buspirone Hcl	Buspirone Hcl	49	12
Myrbetriq	Mirabegron	48	suppressed
Tresiba Flextouch U-100	Insulin Degludec	47	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	11
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	42	35
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	39
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Topiramate	Topiramate	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Finasteride	Finasteride	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	suppressed
Novolog Flexpen	Insulin Aspart	34	suppressed
Cephalexin	Cephalexin	32	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Colestipol Hcl	Colestipol Hcl	31	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	30	30
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	23
Celecoxib	Celecoxib	27	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	11
Irbesartan	Irbesartan	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	16	suppressed
Methylprednisolone	Methylprednisolone	16	13
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Oxycontin	Oxycodone Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Azithromycin	Azithromycin	14	12
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Atenolol	Atenolol	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Diclofenac Potassium	Diclofenac Potassium	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Zafirlukast	Zafirlukast	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error